ALOPECIA UNIVERSALIS

Clinical trials for ALOPECIA UNIVERSALIS explained in plain language.

Never miss a new study

Get alerted when new ALOPECIA UNIVERSALIS trials appear

Sign up with your email to follow new studies for ALOPECIA UNIVERSALIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Head-to-Head hair regrowth trial: can common drugs reverse severe baldness?

Disease control Not yet recruiting

This study will compare two existing oral medications—tofacitinib and methotrexate—for treating severe forms of alopecia areata, an autoimmune condition causing significant hair loss. Seventy-eight adults with severe hair loss will take one of the medications for 12 weeks to see …

Matched conditions: ALOPECIA UNIVERSALIS

Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ALOPECIA UNIVERSALIS

Get alerted when new ALOPECIA UNIVERSALIS trials appear

Head-to-Head hair regrowth trial: can common drugs reverse severe baldness?